This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Innovations of Jean-René Barbier in Osteoporosis Treatment.
Introduction
Jean-René Barbier is a notable inventor based in Gatineau, Canada. He has made significant contributions to the field of medicine, particularly in the treatment of osteoporosis. His innovative work focuses on the development of parathyroid hormone analogues that enhance bone restoration.
Latest Patents
Jean-René Barbier holds a patent for "Parathyroid hormone analogues for the treatment of osteoporosis." This invention relates to analogues of human parathyroid hormone (PTH) that exhibit increased activities in bone restoration and improved bioavailability. The analogues are categorized as either single cyclic (1-28) or (1-29) analogues, or double cyclic (1-28) to (1-31) analogues. The single cyclic analogues are cyclized between amino acid pairs R22 and R26, while the double cyclic analogues are cyclized between amino acid pairs 13 and 17, and 22 and 26. Various substitutions of natural residues for other amino acids are also described, such as substituting the natural Lys27 residue with Leu. These novel analogues demonstrate enhanced abilities to stimulate adenyl cyclase activity in rat osteosarcoma cells and show increased activities in bone restoration using the ovariectomized rat model. He has 1 patent to his name.
Career Highlights
Jean-René Barbier is affiliated with the National Research Council of Canada, where he conducts his research and development work. His focus on parathyroid hormone analogues has positioned him as a key figure in the advancement of osteoporosis treatments.
Collaborations
Throughout his career, Jean-René Barbier has collaborated with esteemed colleagues, including Paul Morley and James F. Whitfield. These collaborations have contributed to the success and impact of his research in the field.
Conclusion
Jean-René Barbier's innovative work in developing parathyroid hormone analogues represents a significant advancement in the treatment of osteoporosis. His contributions continue to influence the medical field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile